Search Results 291-300 of 23863 for prostate cancer
Participation eligibility · Men at least 18 years of age referred with clinical suspicion of prostate cancer. · Serum PSA ≤ 20ng/ml. · Fit to undergo all ...
prostate cancer are expected to be diagnosed this year. "The reality is that prostate cancer is the most commonly diagnosed solid malignancy in men," says ...
The study is the first to capture the methylation changes that occur across the entire human genome in prostate cancer. It's published in the journal Clinical ...
These interactions can play a role in the development of cancer, including breast cancer, prostate cancer, pancreatic cancer, lung cancer and ovarian cancer.
Previous or concurrent malignancy other than non-melanoma skin cancer within 5 years of diagnosis of prostate cancer; Inability to start the protocol ...
About this study. The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.
As chemotherapy and radiation enable patients with breast, lung or prostate cancer or melanoma to live longer, metastatic disease may arise.
“The prostate gland is a gland that sits around the urethra in men just below the bladder. That gland then is responsible for producing semen.” But cancer isn't ...
... prostate cancer treatment. The prostate gland is a part of the male reproductive system. It produces fluid to nourish and protect sperm. Prostate cancer is ...
The purpose of this study is to test how well M1774 works in treating patients with prostate cancer that does not respond to treatment (refractory) and who have ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.